commercialisation

R&D

SK Life Science Leverages Smart, Efficient Solutions Across ...

When SK Life Science began, it tapped into healthcare providers, patients, and scientists t

R&D

Opportunity costs of gene therapies. Where do we go from her...

Over 30 gene therapies have received regulatory approval.

Sales & Marketing

How data is critical to commercialising drugs for rare disea...

Orphan drugs are designed to treat rare diseases, but “rare” is a relative term.

Sales & Marketing

commercialisation of digital innovation - the new frontier

Why commercialisation is the next frontier for digital innov...

In March, Cigna and its pharmacy benefit manager subsidiary Evernorth announced plans to limit spending increases on GLP-1 drugs at 15% per year.

R&D

Embracing a new future-ready pharmacovigilance ecosystem

Following her attendance at DIA Europe 2024, Humaira Qureshi from Qinecsa Solutions, discusses the historic challenges of pharmacovigilance and embracing a new future-ready ecosystem.

R&D

How to optimise commercial-scale ATMP manufacturing through ...

This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance".